| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |